Greenstone Biosciences
PrivateLast Round
Grant
May 15, 2024
Total Funding Raised
$27.26M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Greenstone Biosciences is a biotechnology company that operates a drug discovery platform integrating artificial intelligence, machine learning, and human-induced pluripotent stem cell (hiPSC) technology to accelerate the development of effective therapies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Greenstone Biosciences Comparables
Compare Greenstone Biosciences with similar companies based on industry and business-model similarity.
Greenstone Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 15, 2024 | ||||
| Grant | Apr 29, 2024 | ||||
| Grant | Sep 5, 2023 | ||||
| Grant | Dec 7, 2022 | ||||
| Grant | Oct 4, 2022 | ||||
Seed | May 4, 2022 |
Greenstone Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| A&E Investments | Seed |
| Walden Catalyst | Seed |
| California Institute for Regenerative Medicine | Grant |
| Mayfield Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 44% MoM.
- Apr 16, 2026
Monthly visitors grew 228% MoM, reaching 28.6K.
Greenstone Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Greenstone Biosciences's valuation, stock price, and market status.
Is Greenstone Biosciences a public or private company?
Greenstone Biosciences is a private company.
What is the current stock price of Greenstone Biosciences?
Greenstone Biosciences is a private company, so its shares have no public market price. Caplight tracks Greenstone Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Greenstone Biosciences worth (valuation)?
Valuation information for Greenstone Biosciences is not publicly available.
Can I buy Greenstone Biosciences stock?
Greenstone Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Greenstone Biosciences's last funding round?
Greenstone Biosciences's most recent funding round was Grant on May 15, 2024.
Who are the main investors in Greenstone Biosciences?
Key investors in Greenstone Biosciences include Walden Catalyst.
Will Greenstone Biosciences IPO soon?
No public IPO plans have been announced for Greenstone Biosciences.
How can I track Greenstone Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Greenstone Biosciences's shares on secondary markets.